Drug Approval | November 19, 2024
Shilpa Pharma Lifesciences received CEP from EDQM for API, Octreotide
Octreotide is synthetic peptide manufactured by Shilpa Pharma Lifesciences through solid phase synthesis
Octreotide is synthetic peptide manufactured by Shilpa Pharma Lifesciences through solid phase synthesis
EBITDA for the quarter is Rs. 21.6 crore as against Rs. 18.1 crore in Q2 FY24
This is used to treat central diabetes insipidus and bedwetting
Wanbury receives CEP approval from EDQM for launch of Dextromethorphan API
Ursodeoxycholic acid or ursodiol is a naturally occurring bile acid that is used dissolve cholesterol gall stones
EDQM has also issued a Certificate of Suitability for Allopurino
The certification issued by the EDQM verifies the compliance of pharmaceutical substances
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
